The lipolytic products of TRLs can induce endothelial cell apoptosis and accelerate atherosclerosis progression by increasing oxidative stress via activation of the mitogen-activated protein kinase (MAPK) signaling pathway, ultimately heightening stroke risk and hindering recovery outcomes (35). This evidence concerns the gene WNK2 and stroke disorder.